Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
337.59
+4.62 (1.39%)
At close: Nov 10, 2026, 4:00 PM EST
336.50
-1.09 (-0.32%)
Pre-market: Nov 11, 2026, 4:10 AM EST
PRAX Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 361.85 | 357.33 | 215.37 | 81.3 | 61.62 | 138.7 |
Short-Term Investments | 383.47 | 242 | 177.2 | - | 38.87 | 137.21 |
Cash & Short-Term Investments | 745.32 | 599.33 | 392.57 | 81.3 | 100.49 | 275.91 |
Cash Growth | 178.98% | 52.67% | 382.86% | -19.10% | -63.58% | -6.98% |
Prepaid Expenses | 16.28 | 11.58 | 11.81 | 3.58 | 10.35 | 10.9 |
Restricted Cash | - | - | - | - | - | 0.6 |
Total Current Assets | 762.8 | 610.91 | 404.37 | 84.88 | 110.84 | 287.41 |
Property, Plant & Equipment | 2.58 | 0.24 | 1.36 | 2.65 | 3.87 | 4.87 |
Long-Term Investments | 540.7 | 326.76 | 76.96 | - | - | - |
Other Long-Term Assets | 4 | - | 0.42 | 0.42 | 0.42 | 0.47 |
Total Assets | 1,312 | 937.91 | 483.11 | 87.95 | 115.13 | 292.75 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 15.02 | 24.63 | 12.53 | 5.82 | 14.67 | 10.78 |
Accrued Expenses | 36.75 | 35.03 | 23.76 | 7.42 | 15.85 | 26.84 |
Current Portion of Leases | 0.73 | 0.11 | 1.26 | 1.13 | 1.01 | 0.81 |
Current Unearned Revenue | - | - | - | 1.39 | 2.82 | - |
Total Current Liabilities | 52.5 | 59.77 | 37.55 | 15.75 | 34.35 | 38.43 |
Long-Term Leases | - | - | 0.11 | 1.37 | 2.5 | 3.5 |
Long-Term Unearned Revenue | - | - | - | 1.16 | 2.18 | - |
Total Liabilities | 52.5 | 59.77 | 37.66 | 18.28 | 39.02 | 41.94 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 2,676 | 2,018 | 1,282 | 723.58 | 606.92 | 567.6 |
Retained Earnings | -1,411 | -1,140 | -836.74 | -653.92 | -530.64 | -316.62 |
Comprehensive Income & Other | -5.73 | 0.56 | 0.65 | - | -0.17 | -0.18 |
Total Common Equity | 1,260 | 878.14 | 445.45 | 69.67 | 76.11 | 250.81 |
Shareholders' Equity | 1,260 | 878.14 | 445.45 | 69.67 | 76.11 | 250.81 |
Total Liabilities & Equity | 1,312 | 937.91 | 483.11 | 87.95 | 115.13 | 292.75 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.73 | 0.11 | 1.37 | 2.5 | 3.5 | 4.31 |
Net Cash (Debt) | 1,285 | 925.98 | 468.16 | 78.81 | 96.99 | 271.6 |
Net Cash Growth | 230.64% | 97.79% | 494.07% | -18.75% | -64.29% | -8.20% |
Net Cash Per Share | 45.62 | 41.15 | 26.14 | 11.95 | 31.56 | 95.96 |
Filing Date Shares Outstanding | 27.95 | 27.85 | 20.16 | 13.24 | 3.49 | 3.03 |
Total Common Shares Outstanding | 27.95 | 25.2 | 19.42 | 8.79 | 3.29 | 3.02 |
Working Capital | 710.3 | 551.14 | 366.82 | 69.13 | 76.5 | 248.98 |
Book Value Per Share | 45.07 | 34.85 | 22.93 | 7.92 | 23.12 | 83.05 |
Tangible Book Value | 1,260 | 878.14 | 445.45 | 69.67 | 76.11 | 250.81 |
Tangible Book Value Per Share | 45.07 | 34.85 | 22.93 | 7.92 | 23.12 | 83.05 |
Machinery | - | 1.65 | 1.59 | 1.59 | 1.54 | 1.37 |